HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

5th Edition of International Conference on Tissue Engineering and Regenerative Medicine

September 18-20 | London, UK

September 18 -20, 2025 | London, UK
TERMC 2024

Induction and characterization of human tip-specific endothelial cells

Kara E McCloskey, Speaker at Regenerative Medicine Conferences
University of California, Merced, United States
Title : Induction and characterization of human tip-specific endothelial cells

Abstract:

Defects in vascular cells can contribute to peripheral vascular disease, stroke, atherosclerosis/thrombosis, diabetes, insulin resistance, chronic kidney failure, tumor growth, metastasis, dementia, and some severe viral infectious diseases. However, the recognition of ECs as distinct subphenotypes exhibiting distinct functions has been somewhat controversial. The dominant paradigm previously viewed tip-specific ECs as ECs that temporarily took up their unique behavior while leading migration of a sprouting blood vessel. Newer studies show that tip ECs, as well as ECs subpopulations from different tissue/organs, exhibit phenotypic stability with distinct functional and gene expression profiles, suggesting that these are unique subpopulations of ECs. Our laboratory uses mouse and human embryonic stem cells (ESC) and human induced pluripotent stem (iPS) cells and human umbilical vein endothelial cells (HUVECs) to study endothelial cell functions and vascular development. We have identified soluble signals and unique surface markers that direct and purify tip-specific ECs from stem cells and primary endothelial cells, characterized these cells using a variety of cell markers, and conducted functional assays. Here, we will report on our induction strategies and highlight the differences that we found between mouse and human tip-specific induction and identification. The generation and identification of these specific angiogenic cells are critical in studies aimed at controlling or directing angiogenesis or anti-angiogenesis.

Biography:

Dr. Kara E. McCloskey, PhD, is a Founding Professor at the University of California, Merced in the Chemical and Materials Engineering (CME) Department and Fellow with the American Institute of Medical and Biomedical Engineering (AIMBE). She received her degrees in Chemical Engineering from The Ohio State University and Biomedical Engineering Department at The Cleveland Clinic Foundation and was an NIH-NRSA postdoctoral fellow at Georgia Institute of Technology. Early in her career, Dr. McCloskey was awarded a New Faculty Award from the California Institute of Regenerative Medicine (CIRM) is the Program Directors for a CIRM-funded Training Program in Undergraduate Stem Cell Engineering and Biology (TUSCEB) and the UC Merced Shared Resource Facility (SRL). She has been Founder and Chair of Graduate Program in Biological Engineering and Small-scale Technologies (BEST) and Materials and Biomaterials Science and Engineering (MBSE), and lead developer for UCM’s new B.S. degree in Chemical Engineering. Dr. McCloskey has participated in numerous NSF-funded research centers (CREST-CCBM, STC-CEMB, STC-EBICS and ERC-TARDISS). She is known for her work in directing and characterizing endothelial cells (EC) from embryonic stem cells (ESCs) and induced-pluripotent stem (iPS) cells. She has co-authored over 50 peer-reviewed journal articles in areas from magnetic cell separation, stem cell differentiation, and tissue assembly and is currently focusing her efforts examining cell-material interactions for developing functional tissues.

Watsapp
a